Groclin stock report delayed to November 6 after accounting review

Published on 10/30/2026 at 01:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Groclin stock now faces a later half-year filing after the issuer revised its accounting approach. The report is due in early November.

Filing delay and accounting review

The issuer revised its reporting timetable after reviewing the accounting treatment of an acquisition.
Interim financial statement review work with the auditor was not complete when the announcement was issued.
The report concerns the first half of the 2026 financial year.

Groclin, PLINTGR00013, Illustration mit AI erstellt.

Luna Global S.A., the issuer associated with Groclin under ISIN PLINTGR00013, has postponed publication of its consolidated report for the first half of 2026. In a Warsaw Stock Exchange ESPI/EBI report dated October 28, the company said the filing timetable had been revised.

The report had previously been scheduled for October 30. Luna Global said the new publication date is November 6, following a review of the accounting method for its acquisition of 100% of Luna Corporate sp. z o.o. The company added that work on reviewing its interim financial statements with its auditor had not been completed when the announcement was issued.

Why the filing was postponed

The announcement concerns the reporting process rather than a disclosed change to the half-year results. The reporting period runs from January 1 through June 30, 2026, and the company did not provide new financial figures in the notice.

What investors should watch

Investors will be able to assess the effect of the accounting treatment and the acquired business once the half-year report is published. Until then, the delay leaves the relevant interim financial information unavailable through the announced filing timetable.